Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Freudenberg

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Nuclear Medicine and Molecular Imaging|July 14, 2010
The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imagingWalter Jentzen, Dorothee Balschuweit, Jochen Schmitz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 12, 2007
Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systemsWalter Jentzen, Reiner Weise, Jürgen Kupferschläger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 11, 2022
A 2022 International Survey on the Status of Prostate Cancer TheranosticsThomas Beyer, Johannes Czernin, Lutz Freudenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 2012
Recombinant human TSH versus thyroid hormone withdrawalFrederik A Verburg, Markus Dietlein, Lutz Freudenberg, et al.
Nuclear Medicine Communications|July 11, 2006
Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancerWalter Jentzen, Elke Schneider, Lutz Freudenberg, et al.
European Journal of Endocrinology|December 3, 2005
Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatmentSefik Tagay, Stephan Herpertz, Matthias Langkafel, et al.
Radiology|November 27, 2004
Unknown primary tumors: detection with dual-modality PET/CT--initial experienceAndreas Gutzeit, Gerald Antoch, Hilmar Kühl, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Nuclear Medicine and Molecular Imaging|July 14, 2010
The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imagingWalter Jentzen, Dorothee Balschuweit, Jochen Schmitz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 12, 2007
Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systemsWalter Jentzen, Reiner Weise, Jürgen Kupferschläger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 11, 2022
A 2022 International Survey on the Status of Prostate Cancer TheranosticsThomas Beyer, Johannes Czernin, Lutz Freudenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 2012
Recombinant human TSH versus thyroid hormone withdrawalFrederik A Verburg, Markus Dietlein, Lutz Freudenberg, et al.
Nuclear Medicine Communications|July 11, 2006
Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancerWalter Jentzen, Elke Schneider, Lutz Freudenberg, et al.
European Journal of Endocrinology|December 3, 2005
Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatmentSefik Tagay, Stephan Herpertz, Matthias Langkafel, et al.
Radiology|November 27, 2004
Unknown primary tumors: detection with dual-modality PET/CT--initial experienceAndreas Gutzeit, Gerald Antoch, Hilmar Kühl, et al.
Pageof 2